The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects.

Hwang, Sejung; Lee, Soyoung; Kim, Eunwoo; Hwang, Inyoung; Cho, Joo-Youn; Chung, Jae-Yong; Jang, In-Jin; Oh, Jaeseong

Hwang, Sejung; Lee, Soyoung; Kim, Eunwoo; Hwang, Inyoung; Cho, Joo-Youn; Chung, Jae-Yong; Jang, In-Jin; Oh, Jaeseong.

Affiliation

Hwang S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine, Seoul, Korea.
Lee S; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Korea.
Kim E; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine, Seoul, Korea.
Hwang I; Kidney Research Institute, Seoul National University Medical Research Center, Seoul, Korea.
Cho JY; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine, Seoul, Korea.
Chung JY; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine, Seoul, Korea.
Jang IJ; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine, Seoul, Korea.
Oh J; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.

Clin Transl Sci ; 15(9): 2116-2126, 2022 09.

Article in En | MEDLINE | ID: mdl-35727711

Subject(s)

Anticonvulsants; Seizures; Adult; Dibenzazepines; Double-Blind Method; Humans; Republic of Korea; Seizures/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Seizures / Anticonvulsants Type of study: Clinical_trials Limits: Adult / Humans Country/Region as subject: Asia Language: En Journal: Clin Transl Sci Year: 2022 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google